ORTEXORTEX News
Tracking EGBN? Get live short interest, options flow, and signals on ORTEX.Sign up free →
EG
Trader NoteEGBN

Eagle Bancorp Heads Into Earnings With Shorts Building and Options Bulls Dominant

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 21 Oct 2026, 21:24

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

EGBN reports third-quarter results on October 22 with short sellers adding quietly to positions, options traders leaning unusually bullish, and the Street freshly more optimistic after a year of slow rehabilitation.

Short interest has climbed steadily, and that trend is now the clearest tension heading into tomorrow's print. Bears have built a 16% larger position over the past month, taking short interest to nearly 11% of free float, one of the more meaningful short positions in the regional bank space. The week-on-week gain of about 2.7% adds to a run that started in mid-September, when roughly 2.75 million shares were short versus 3.34 million today. Despite that build, the borrow market is not under stress. Availability is ample at 556%, meaning roughly five-and-a-half shares remain available to borrow for every one already lent out, well above the 52-week tightest point of 294%. Borrowing costs are low at 0.55%, up about 11% on the week but historically unremarkable. The short-score reading of 65.6 is elevated but has been essentially flat for the past two weeks, suggesting the build is measured rather than urgent.

Options positioning tells the opposite story. Call demand is running far above what is normal, with the put/call ratio at just 0.06, roughly 1.3 standard deviations below its 20-day average of 0.17. That puts options traders in their most bullish configuration in recent memory, with the PCR near the 52-week low of 0.04. The contrast with the short book is stark: one group is hedging for upside, the other is positioned for further pressure. The setup into earnings is genuinely two-sided.

The Street has turned more constructive over the past six months. Hovde Group initiated coverage on October 7 with an Outperform rating and a $37 target, the most bullish call on the register. Raymond James initiated in April at Strong Buy with a $32 target. Piper Sandler, which spent much of 2025 cutting its target as low as $18, has since raised it steadily to $30 while remaining at Neutral. The consensus is a buy, with a mean price target of $32.17, about 13% above the current price of $28.56. Valuation is modest: the stock trades at 0.71 times book and roughly 12.8 times trailing earnings, multiples that reflect the credit rehabilitation story still in progress. The forward EPS year-on-year improvement factor ranks in the 95th percentile of the universe, and analyst recommendation momentum ranks in the 90th, both pointing to a Street that is catching up to a turnaround it was slow to credit.

The FDIC call report data from Eagle's insured bank charter flags two facts worth noting ahead of the print. Total deposits in the April 2026 quarter were the smallest Q2 on record in the dataset going back to 2024. Net loans and leases have fallen for five consecutive quarters, with the latest reading at $6.55 billion. Neither dataset has been measured to lead the company's reported figures, so these are colour rather than signals, but they describe a bank still shrinking its balance sheet even as credit quality improves. The bear case centres on exactly that tension: criticized loan levels remain elevated, reserves continue to build, and the stock may need several more clean quarters before its price-to-book discount closes. The bull case is that the trajectory on non-performing assets and criticized balances is improving, and a bank trading at 0.71 times book with a strengthening forward earnings revision trend has room to re-rate.

Institutional ownership gives some context on who is holding through the recovery. BlackRock holds 13.8% of shares, the largest single position, and added 159,000 shares in the most recent quarter. T. Rowe Price added 350,000 shares to reach 5.7% of shares outstanding. North Reef Capital, which once held close to 10% of the company, has reduced its stake to 5.6% over the past year. The Vanguard Group's 13G/A filing in March 2026 reported a position of zero, down from 7% previously. As always with 13D/G disclosures, stakes are as last reported around the 5% threshold, and holders dropping below that level may not file again. Insider activity in the window is low-signal: recent filings show tax-withholding transactions and compensation awards with no open-market purchases or sales.

The October 22 print is the first test of whether the improvement in asset quality metrics has translated into a cleaner income statement, and whether deposit trends have stabilised after the record-low Q2 reading.

Stocks in this article

See the live data behind this article on ORTEX.

Open EGBN on ORTEX →

How this article was generated

Generated
21 Oct 2026, 21:24
Data as of
21 Oct 2026, 21:24
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.